Feinstein Kean Healthcare

Feinstein Kean Healthcare is the premier health care communications firm in the industry. For more than 20 years, Feinstein Kean has provided strategic communications services for hundreds of pharmaceutical, biotechnology, diagnostics, industry and policy associations, and health care services clients. Feinstein Kean pioneered the use of science-based communications to drive both visibility and credibility for its clients. The company is differentiated from other firms by the depth of its scientific understanding and the integrated way in which it is able to function at the intersection of science, business, clinical practice and public interest. In addition to being trusted with building the brands and markets for the world's leading pharmaceutical companies, Feinstein Kean has been at the forefront of the emerging personalized medicine sector. Feinstein Kean Healthcare is a wholly owned subsidiary of Ogilvy Public Relations Worldwide, one of the top 10 global PR agencies. However, it has chosen to remain a distinct entity, smaller and specialized, to help preserve our boutique qualities – depth of knowledge, personalized approach and great flexibility.